ET
WST icon

Entropy Technologies’s West Pharmaceutical WST Stock Holding History

Entropy Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,937
Closed -$424K – 1125
2025
Q2 		$424K Buy
+1,937
New +$414K 0.03% 525
2024
Q4 		– Sell
-737
Closed -$221K – 1035
2024
Q3 		$221K Buy
+737
New +$226K 0.02% 616
2024
Q2 		– Sell
-4,281
Closed -$1.69M – 969
2024
Q1 		$1.69M Buy
4,281
+1,547
+57% +$572K 0.18% 167
2023
Q4 		$963K Buy
+2,734
New +$968K 0.18% 198

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Entropy Technologies's WST Position: Q3 2025 in Review

Entropy Technologies sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1,937 shares — an estimated $424K sold.

Entropy Technologies first reported a position in WST in Q4 2023 and held it in 4 quarters. The position peaked at $1.69M in Q1 2024. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Entropy Technologies reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Entropy Technologies sold 1,937 West Pharmaceutical shares in Q3 2025, an estimated $424K.
  • Entropy Technologies first reported a position in West Pharmaceutical in Q4 2023 and held it in 4 quarters.
  • Entropy Technologies's West Pharmaceutical position peaked at $1.69M in Q1 2024.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Entropy Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.